SRT1720 hydrochloride 10 mg | 99.59%
TargetMol
SRT 1720 is a selective activator of SIRT1 (EC1.5: 0.16 μM) and shows less potent activities on SIRT2/SIRT3 (EC1.5s: 37 μM/300 μM).
More Information Supplier PageSRT1720 hydrochloride
Search Results
LY294002 50 mg | 99.76%
TargetMol
LY294002 is an inhibitor of PI3K (IC50s: 0.5/0.57/0.97 μM for PI3Kα/δ/β in cell-free assays). It also blocks autophagosome formation.
More Information Supplier PageLY294002
LY294002 200 mg | 99.76%
TargetMol
LY294002 is an inhibitor of PI3K (IC50s: 0.5/0.57/0.97 μM for PI3Kα/δ/β in cell-free assays). It also blocks autophagosome formation.
More Information Supplier PageLY294002
LY294002 100 mg | 99.76%
TargetMol
LY294002 is an inhibitor of PI3K (IC50s: 0.5/0.57/0.97 μM for PI3Kα/δ/β in cell-free assays). It also blocks autophagosome formation.
More Information Supplier PageLY294002
SRT1720 hydrochloride 2 mg | 99.59%
TargetMol
SRT 1720 is a selective activator of SIRT1 (EC1.5: 0.16 μM) and shows less potent activities on SIRT2/SIRT3 (EC1.5s: 37 μM/300 μM).
More Information Supplier PageSRT1720 hydrochloride
SRT1720 hydrochloride 25 mg | 99.59%
TargetMol
SRT 1720 is a selective activator of SIRT1 (EC1.5: 0.16 μM) and shows less potent activities on SIRT2/SIRT3 (EC1.5s: 37 μM/300 μM).
More Information Supplier PageSRT1720 hydrochloride
Idelalisib 5 mg | Purity Not Available
TargetMol
Idelalisib is a small molecule inhibitor of the PI3K catalytic subunit p110δ (IC50: 2.5 nM). The selectivity for p110δ is 40- to 300-fold than p110α/β/γ.
More Information Supplier PageIdelalisib
Idelalisib 50 mg | Purity Not Available
TargetMol
Idelalisib is a small molecule inhibitor of the PI3K catalytic subunit p110δ (IC50: 2.5 nM). The selectivity for p110δ is 40- to 300-fold than p110α/β/γ.
More Information Supplier PageIdelalisib
Idelalisib 200 mg | Purity Not Available
TargetMol
Idelalisib is a small molecule inhibitor of the PI3K catalytic subunit p110δ (IC50: 2.5 nM). The selectivity for p110δ is 40- to 300-fold than p110α/β/γ.
More Information Supplier PageIdelalisib
Idelalisib 10 mg | Purity Not Available
TargetMol
Idelalisib is a small molecule inhibitor of the PI3K catalytic subunit p110δ (IC50: 2.5 nM). The selectivity for p110δ is 40- to 300-fold than p110α/β/γ.
More Information Supplier PageIdelalisib